Fragile X at a turning point: Breaking through the clinical bottleneck
In this episode of Denatured, you’ll hear from Hilary Rosselot, executive director at the National Fragile X Foundation and Jordi Fàbrega, co-founder & CEO at CONNECTA Therapeutics. From trial endpoints and placebo effects to neuroplasticity modulation, we explore what it will take to build a sustainable path to the first approved therapy.
News Drug Development Fragile X at a turning point: Breaking through the clinical bottleneck August 27, 2026 | 1 min read | Jennifer C. Smith-Parker, BioSpace Insights Twitter LinkedIn Facebook Email Print In this episode of Denatured, you’ll hear from Hilary Rosselot, executive director at the National Fragile X Foundation and Jordi Fàbrega, co-founder & CEO at CONNECTA Therapeutics. From trial endpoints and placebo effects to neuroplasticity modulation, we explore what it will take to build a sustainable path to the first approved therapy.
> Listen on Spotify> Listen on Apple Podcasts> Listen on Amazon Music> Watch on YouTubeIn this episode of Denatured, you’ll listen to Hilary Rosselot, executive director at the National Fragile X Foundation and Jordi Fàbrega, co-founder & CEO at CONNECTA Therapeutics. From the challenge of credible endpoints and persistent placebo effects to the promise of neuroplasticity modulation, we examine the steps needed to move the field toward its first approved therapy.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsHilary Rosselot, Executive Director, National Fragile X FoundationJordi Fàbrega, Co-Founder & CEO, CONNECTA TherapeuticsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
Twitter LinkedIn Facebook Email Print Podcasts BioSpace Insights Denatured Clinical research Europe Rare diseases Regulatory Patient recruitment FDA Patient advocacy Fragile X Jennifer C. Smith-Parker Jennifer C. Smith-Parker is Director of Insights at BioSpace.
She has been been immersed for 20 years in healthcare, first as a journalist and editor before pivoting to corporate, brand, and product communications. A skilled storyteller, she is adept at creating diverse content across platforms and crafting narratives that drive engagement, strengthen reputation, and deliver measurable growth. You can reach her at Jennifer.Smith-Parker@BioSpace.com.
BioSpace Insights The BioSpace Insights teams performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.
comments(0)
5-min edit window · permanent after that